Swipe through the latest business and wealth clues with our android app

Glenmark Pharmaceuticals Q4 PAT seen up 30% YoY to Rs. 196.4 cr: Prabhudas Lilladher

Prabhudas Lilladher has come out with its fourth quarter (January-March’ 19) earnings estimates for the Pharma sector. The brokerage house expects Glenmark Pharmaceuticals to report net profit at Rs. 196.4 crore up 30% year-on-year (up 68.8% quarter-on-quarter). Net Sales are expected to increase by 10.8% Y-o-Y (down 0.8% Q-o-Q) to Rs. 2,490.2 crore

Read More at Moneycontrol News date : 12 Apr 2019, Friday

©2019 TheNewsClues